Prevalence and Factors Associated With the Informal Market for Medicines in Benin: A Community-Based Cross-Sectional Study

贝宁非正规药品市场的流行情况及其相关因素:一项基于社区的横断面研究

阅读:1

Abstract

BACKGROUND AND AIMS: Medicines are intended to improve the health of individuals with various medical conditions, but their poor-quality poses significant risks, especially in low- and middle-income countries like Benin, where informally sold medicines are widely consumed. This study assessed the prevalence and factors associated with their consumption in Benin. METHODS: Conducted in 2018 across 72 districts of Cotonou, it targeted 864 households. Data collected included the consumption of these medicines, along with sociodemographic and socioeconomic information, as well as medicine-related practices such as purchasing habits, self-medication, medical consultation, access to the informal market, awareness of risks, and reasons for consumption. RESULTS: The results revealed a pattern of multiple-source medicine procurement, with 25.5% (95% CI: 22.5%-28.5%) of individuals reporting the use of informally sold medicines, despite 83.84% of households obtaining medicines from pharmacies and a health service utilization rate of 58.1%. Factors associated with informal medicine consumption included a lack of awareness of the risks (PR = 2.31; 95% CI: 1.57-3.40; p < 0.001), exposure to malaria or pains (PR = 2.02; 95% CI: 1.04-3.94; p = 0.04), self-medication (PR = 95.02; 95% CI: 25.57-353.15; p < 0.001), frequent purchases (PR = 1.90; 95% CI: 1.16-3.10; p = 0.01), irregular medicine availability in pharmacies (PR = 3.42; 95% CI: 2.26-5.16; p < 0.001), and other sources purchases (PR = 15.21; 95% CI: 7.52-30.78; p < 0.001). CONCLUSION: Informal medicine use remains prevalent in Benin and is significantly driven by lack of awareness, exposure to malaria or pains, self-medication, frequent purchases, irregular medicine availability, and infrequent pharmacies use. Addressing this issue requires strategic interventions such as raising public awareness and improving availability and access to quality medicines through authorized facilities.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。